These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15868999)

  • 21. The antinociceptive effect of nalbuphine and its long-acting esters in rats.
    Chu KS; Wang JJ; Yoa-Pu Hu O; Ho ST; Chen YW
    Anesth Analg; 2003 Sep; 97(3):806-809. PubMed ID: 12933406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of early neonatal experience on nociceptive responses and analgesic effects in rats.
    Dickinson AL; Leach MC; Flecknell PA
    Lab Anim; 2009 Jan; 43(1):11-6. PubMed ID: 18987062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The analgesic effect of nalbuphine and its long-acting prodrug, nalbuphine pivalate, in rats.
    Chen KT; Hu OY; Ho ST; Chen YW; Wang JJ
    Acta Anaesthesiol Sin; 2002 Dec; 40(4):191-5. PubMed ID: 12596618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats.
    Bulka A; Kouya PF; Böttiger Y; Svensson JO; Xu XJ; Wiesenfeld-Hallin Z
    Eur J Pharmacol; 2004 May; 492(1):27-34. PubMed ID: 15145702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.
    La Vincente SF; White JM; Somogyi AA; Bochner F; Chapleo CB
    Clin Pharmacol Ther; 2008 Jan; 83(1):144-52. PubMed ID: 17568402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of buprenorphine on behaviour in the ACI and BN rat inbred strains.
    Avsaroglu H; Sommer R; Hellebrekers LJ; van Zutphen LF; van Lith HA
    Lab Anim; 2008 Apr; 42(2):171-84. PubMed ID: 18435875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats.
    Kitamura T; Ogawa M; Kawamura G; Sato K; Yamada Y
    Anesth Analg; 2009 Nov; 109(5):1479-85. PubMed ID: 19843785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine reduces central sensitization after repetitive C-fiber stimulation in rats.
    Kouya PF; Xu XJ
    Neurosci Lett; 2004 Apr; 359(1-2):127-9. PubMed ID: 15050727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antinociceptive and anti-inflammatory effects of five depot formulations of ketorolac propyl ester in rats.
    Wang LK; Wang PJ; Hou CH; Chu CC; Tzeng JI; Shieh JP; Wang JJ
    Acta Anaesthesiol Taiwan; 2005 Jun; 43(2):85-92. PubMed ID: 16060403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
    Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
    Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational medicine in ultra-long injectable opioid drug discovery--when abuse liability and toxicity meet analgesic efficacy.
    Sun WZ
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):133-4. PubMed ID: 17036999
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.
    Koppert W; Ihmsen H; Körber N; Wehrfritz A; Sittl R; Schmelz M; Schüttler J
    Pain; 2005 Nov; 118(1-2):15-22. PubMed ID: 16154698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics.
    Yassen A; Olofsen E; Dahan A; Danhof M
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1136-49. PubMed ID: 15701707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats.
    Guarnieri M; Brayton C; DeTolla L; Forbes-McBean N; Sarabia-Estrada R; Zadnik P
    Lab Anim (NY); 2012 Nov; 41(11):337-43. PubMed ID: 23079917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinociceptive effects of epidural buprenorphine or medetomidine, or the combination, in conscious cats.
    Steagall PV; Millette V; Mantovani FB; Gilbert P; Luna SP; Duke-Novakovski T
    J Vet Pharmacol Ther; 2009 Oct; 32(5):477-84. PubMed ID: 19754915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A long-form alpha-neurotoxin from cobra venom produces potent opioid-independent analgesia.
    Chen ZX; Zhang HL; Gu ZL; Chen BW; Han R; Reid PF; Raymond LN; Qin ZH
    Acta Pharmacol Sin; 2006 Apr; 27(4):402-8. PubMed ID: 16539838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
    Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.